Tradestie Institutional Equity Comparison Engine
SKIN vs FIGS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
FIGS Overall Edge
FIGS Captures Institutional Edge (3โ1 Pillars ยท 9โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to FIGS, Inc. (FIGS) driven by superior Valuation, Growth & Margin, Options & Structure while SKIN counters with relative strength in Momentum & Technical. Fundamentally, SKIN trades at 106.4x Forward P/E with 2.4% operating margin (-2.1% YoY revenue) versus FIGS at 49.2x Forward P/E and 9.7% operating margin (+25.7% YoY). In options structure, SKIN sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro) against FIGS sits in BREAKOUT (38th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
FIGS
SKIN 106.4x vs FIGS 49.2x Fwd P/E
Growth & Margin Winner
FIGS
Op Margin 2.4% vs 9.7% ยท YoY -2.1% vs +25.7%
Momentum & Technical Winner
SKIN
1Y +1057.7% vs +127.0% ยท 52W Pos 83% vs 84%
Options & Structure Winner
FIGS
UNCLASSIFIED (100th %ile IV) vs BREAKOUT (38th %ile IV)
SKIN
NASDAQ
The Beauty Health Company Class A Common Stock
Surgical & Medical Instruments & Apparatus
$15.05
-7.73% 1D
Market Cap
$106.3M
1M Return
+42.52%
1Y Return
+1057.69%
Forward P/E
106.4x
Unified AI Score
34.1 / 100
SELL
Tech 50.0
Fund 34.0
Flow 67.0
Mom 46.0
FIGS
NYSE
FIGS, Inc.
Apparel & Other Finishd Prods Of Fabrics & Similar Matl
$21.34
-3.22% 1D
Market Cap
$3.7B
1M Return
+11.61%
1Y Return
+127.02%
Forward P/E
49.2x
Unified AI Score
43.7 / 100
HOLD
Tech 30.0
Fund 35.0
Flow 68.0
Mom 1.1
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
SKIN +1057.69%
FIGS +127.02%
Spread: +930.67 pp (SKIN Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | SKIN Revenue | FIGS Revenue | SKIN Op. Margin | FIGS Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $170M | $110M | 8.1% | -0.3% | SKIN |
| FY2020 | $120M | $260M | -14.4% | 22.0% | FIGS |
| FY2021 | $260M | $420M | -15.4% | 2.6% | FIGS |
| FY2022 | $370M | $510M | -7.1% | 7.4% | FIGS |
| FY2023 | $400M | $550M | -32.9% | 6.2% | FIGS |
| FY2024 | $330M | $560M | -20.3% | 0.4% | FIGS |
| FY2025 | $300M | $630M | -6.9% | 6.0% | FIGS |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | SKIN | FIGS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $106.3M | $3.7B | Larger Scale | FIGS |
| Trailing P/E Ratio Valuation | 106.4x | 58.0x | Lower Multiple | FIGS |
| Forward P/E Ratio Valuation | 106.4x | 49.2x | Lower Multiple | FIGS |
| Revenue Growth (YoY) Growth | -2.1% | +25.7% | Higher Growth | FIGS |
| Operating Margin (TTM) Profitability | 2.4% | 9.7% | Higher Margin | FIGS |
| Net Profit Margin Profitability | -6.3% | 9.7% | Higher Margin | FIGS |
| Return on Equity (ROE) Capital Efficiency | -30.1% | 16.8% | Higher ROE | FIGS |
| 52-Week Range Position Momentum | 83% ($0โ$18) | 84% ($9โ$24) | Stronger Trend | Tie |
| Beta / 30D Volatility Risk Regime | -14.22ฮฒ ยท 192% Vol | 1.10ฮฒ ยท 59% Vol | Lower Realized Risk | FIGS |
| Unified Institutional Score Composite Signal | 34.1 / 100 (SELL) | 43.7 / 100 (HOLD) | Higher Composite | FIGS |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full SKIN vs FIGS Buy Guide
SKIN
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
FIGS
BREAKOUT
22d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
38th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither SKIN nor FIGS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.